The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...

According to data from amfAR, the Foundation for AIDS Research, about 1.3 million people are on HIV/AIDS treatment in Kenya, ...

South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded ...

Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...

The decline in D.C. HIV cases is a positive trend, but funding cuts could impact future prevention work. Derrick “Strawberry” ...

A US aid freeze means that Nyumbani Children’s Homes' access to antiretroviral drugs may end soon. US President Donald ...

The median (IQR) age of the people living with HIV (PLWH) was 49 (38-57) years, with the recently-arrived GBM having a median ...

All patients who get shots of antiretroviral medication at Prevention Point's Sana Clinic now have undetected levels of the ...

One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...

A new HIV drug, lenacapavir, appears highly effective against strains circulating in Uganda, according to a study led by ...

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...

A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.